PEBC Part I (MCQ) · Competency 1A Clinical Care (about 50% of Part I)
These items apply therapeutics to pediatrics, older adults, pregnancy and lactation, oncology supportive care, urology, ophthalmology and transplant medicine, where the same drug can be right for one patient and harmful for another.
1A Clinical Care2 min read6 sections
Checked against the SOGC folic acid guideline No. 427 (2022) and other SOGC guidance; 2023 AGS Beers Criteria; ATA pregnancy thyroid guideline (2017); MASCC/ESMO and ASCO antiemetic guidelines; Canadian Urological Association guidance; Thrombosis Canada pregnancy guide; Health Canada product monographs; checked 13 Oct 2026. Not affiliated with or endorsed by The Pharmacy Examining Board of Canada (PEBC).
Cases combine a population with a drug decision: an 8-week-pregnant patient on several drugs, a frail resident with polypharmacy, or a breastfeeding mother needing analgesia.
Check every drug at preconception visits, not after a positive test.
Budesonide is the inhaled corticosteroid with the most pregnancy data.
Doxylamine-pyridoxine is first line for nausea and vomiting of pregnancy.
Every note. Every question. One pass.
4 more sections of this note are part of Premium.
From about C$16.58/mo on the Until-you-pass pass (12 months)
Educational practice material for exam preparation only. Not medical advice and not a substitute for current product monographs, clinical guidelines or professional judgement. Questions have not yet been reviewed by a licensed pharmacist.
